GO Term | Evidence Code | PMID |
---|---|---|
determination of liver left/right asymmetry | ||
metanephric ascending thin limb development | ||
cellular response to calcium ion | ||
branching involved in ureteric bud morphogenesis | ||
embryonic placenta development |
GO Term | Evidence Code | PMID |
---|---|---|
basal cortex | ||
motile cilium | ||
ciliary basal body | ||
endoplasmic reticulum | ||
cytosol |
GO Term | Evidence Code | PMID |
---|---|---|
cytoskeletal protein binding | ||
ATPase binding | ||
monoatomic cation channel activity | ||
calcium channel activity | ||
muscle alpha-actinin binding |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
DO ID | Disease Name | Source |
---|---|---|
DOID:1612 | breast cancer | |
DOID:162 | cancer | |
DOID:1682 | congenital heart disease | |
DOID:1799 | islet cell tumor | |
DOID:1923 | disorder of sexual development | |
DOID:2527 | nephrosis | |
DOID:2797 | idiopathic interstitial pneumonia | |
DOID:2876 | laryngeal squamous cell carcinoma | |
DOID:2921 | glomerulonephritis | |
DOID:2975 | cystic kidney disease |
HPO ID | HPO Term |
---|---|
HP:0003259 | Elevated circulating creatinine concentration |
HP:0003596 | Middle age onset |
HP:0003621 | Juvenile onset |
HP:0003676 | Progressive |
HP:0003774 | Stage 5 chronic kidney disease |
HP:0003829 | Typified by incomplete penetrance |
HP:0004944 | Dilatation of the cerebral artery |
HP:0005562 | Multiple renal cysts |
HP:0006254 | Elevated circulating alpha-fetoprotein concentration |
HP:0006557 | Polycystic liver disease |
Disease ID | Disease Name |
---|---|
ORPHA:730 |
|
OMIM:613095 |
|
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
101098948 | FELCA08690 | ||
122218061 | PANLE27326 | ||
118895571 | BALMU27637 | ||
100669961 | LOXAF10324 | ||
100063439 | HORSE30629 | ||
102174641 | CAPHI26234 | ||
105995935 | DIPOR16443 | ||
18764 | MGI:1099818 | MOUSE43586 | |
498328 | RGD:1559992 | RATNO08534 | |
101564560 | OCTDE06016 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024